Inhibition of human immunodeficiency virus 1 (HIV-1) and herpes simplex virus 1 (HSV-1) infectivity with a broad range of lectins

References

• McDougal J S, Kennedy M S, Sligh J M, Cort S P, Mawle A, Nicholson J KA. Binding of HTLV‐III/LAV to T4+T cells by a complex of the 110K viral protein and the T4 molecule. Science 1986; 231: 382–385
   PubMed Web of Science ®Google Scholar
• Lifson J D, Feinberg M B, Reyes G R, Rabin L, Banapour B, Chakrabartil S, Moss B, Wong‐Staal F, Steimer K S, Engleman E. Induction of CD4‐dependent cell‐fusion by the HTLV‐III/LAV envelope glycoprotein. Nature 1986; 323: 725–728
   PubMed Web of Science ®Google Scholar
• Datema R, Olofsson S, Romero P A. Inhibitors of protein glycosylation and glycoprotein processing in viral systems. Pharmacol Ther 1987; 33: 221–286
   PubMed Web of Science ®Google Scholar
• Fuller A O, Spear P G. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. J Virol 1985; 55: 475–482
   PubMed Web of Science ®Google Scholar
• Matthews T J, Weinhold K J, Lyerly H K, Langlios A J, Wigzell H, Bolognesi D P. Interaction between the human T‐cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: Role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci USA 1987; 84: 5424–5428
   PubMed Web of Science ®Google Scholar
• Hansen J ‐ES, Nielsen C M, Nielsen C, Heegaard P, Mathiesen L R, Nielsen J O. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV‐1 and HIV‐2 and syncytium inhibition with lectins. AIDS 1989; 3: 635–641
   PubMed Web of Science ®Google Scholar
• Mizuochi T, Matthews T J, Kato M, Hamako J, Titani K, Solomon J, Feizi T. Diversity of oligosaccharide structure on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. J Biol Chem 1990; 265: 8519–8524
   PubMed Web of Science ®Google Scholar
• Hansen J ‐ES, Clausen H, Nielsen C, Teglbjærg L S, Hansen L L, Nielsen C M, Dabelsteen E, Mathiesen L, Hakomori S, Nielsen J O. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anti‐carbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J Virol 1990; 64: 2833–2840
   PubMed Web of Science ®Google Scholar
• CampadelliFiume G, Poletti L, Dall'Olio F, Serafini‐Cessi F. Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin‐resistent cell line deficient in N‐acetylglucosaminyl transferase I. J Virol 1982; 43: 1061–1071
   PubMed Web of Science ®Google Scholar
• Wenske E A, Bratton M E, Courtney R J. Endo‐ß‐N‐nacetylglucosaminidase H sensitivity of precursors to herpes simplex virus type 1 glycoproteins gB and gC. J Virol 1982; 44: 241–248
   PubMed Web of Science ®Google Scholar
• Olofsson S, Blomberg J, Lycke E. O‐glycosidic carbohydrate‐peptide linkages of herpes simplex virus glycoproteins. J Virol 1981; 70: 321–329
   Google Scholar
• Olofsson S, Sjöblom I, Lundström M, Jeansson S, Lycke E. Glycoprotein C of herpes simplex virus type 1: Characterization of O‐linked oligosaccharides. J Gen Virol 1983; 64: 2735–2747
   PubMed Web of Science ®Google Scholar
• Svennerholm B, Olofsson S, Lundén R, Vahlne A, Lycke E. Adsorption and penetration of enveloped herpes simplex virus particles modified by tunicamycin or 2‐deoxy‐D‐glucose. J Gen Virol 1982; 63: 343–349
   PubMed Web of Science ®Google Scholar
• Olofsson S, Sjöblom I, Jeansson S. Activity of herpes simplex virus type 1‐specified glycoprotein C antigenic site II epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharides. J Gen Virol 1990; 71: 889–895
   PubMed Web of Science ®Google Scholar
• Hammar L, Eriksson S, Morein B. Human immunodeficiency virus glycoproteins: lectin binding properties. AIDS Res Hum Retroviruses 1989; 5: 495–506
   PubMed Web of Science ®Google Scholar
• Robinson W E, Montefiori D C, Mitchell W M. Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV‐1) pathogenesis. AIDS Res Human Retroviruses 1987; 3: 265–282
   PubMed Web of Science ®Google Scholar
• Ito M, Barron A L. Inactivation of herpes simplex virus by concanavalin A. J Virol 1974; 13: 1312–1318
   PubMed Web of Science ®Google Scholar
• Popovic M, Sarngadharan M G, Read E, Gallo R C. Detection, isolation and continuous production of cytopathic retroviruses (HTLV‐III) from patients with AIDS and pre‐AIDS. Science 1984; 224: 497–500
   PubMed Web of Science ®Google Scholar
• Harada S, Koyanagi Y, Yamamoto N. Infection of HTLV‐III/LAV in HTLV‐I‐carrying cells MT‐2 and MT‐4 and application in a plaque assay. Science 1985; 229: 563–566
   PubMed Web of Science ®Google Scholar
• Lerhøj J. Cytopathic effect of rubella virus in a rabbit cornea cell line. Science 1965; 149: 633–634
   PubMed Web of Science ®Google Scholar
• Nielsen C M, Bygbjerg I C, Vestergaard B F. Detection of HIV antigens in eluates from whole blood collected on filter paper. Lancet 1987; 1: 566–567
   PubMed Web of Science ®Google Scholar
• Vestergaard B F, Hornsleth A, Pedersen S N. Occurrence of herpes‐ and adenovirus antibodies in patients with carcinoma of the cervix uteri. Cancer 1972; 30: 68–74
   PubMed Web of Science ®Google Scholar
• Vestergaard B F. Crossed immunoelectrophoretic characterization of herpesvirus hominis type 1 and 2 antigens. Acta Pathol Microbiol Scand 1973; 81: 808–810
   Google Scholar
• Geyer H, Holschbach C, Hunsmann G, Schneider J. Carbohydrates of human immunodeficiency virus. J Biol Chem 1988; 263: 11760–11767
   PubMed Web of Science ®Google Scholar
• Lundström M, Olofsson S, Jeansson S, Lycke E, Datema R, Månsson J ‐E. Host cell‐ induced differences in O‐glycosylation of herpes simplex gC‐1. Virology 1987; 161: 385–394
   PubMed Web of Science ®Google Scholar